In human prostate cancer cell lines, Long-R3 IGF-I raised telomerase activity about 3-fold.
In plain wordsIn lab tests on prostate cancer cells, Long-R3 IGF-I raised telomerase activity about 3-fold.
- Peptide
- IGF-1 LR3
- Outcome
- IncreaseTelomerase activity
- Study
humann: not reported in source
Human prostate cancer cell lines (LAPC-4, PC-3, DU-145)- Outcome group
- Tumor growth · Cancer
- Studied dose
- Dose not stated
Measurements
- Telomerase activity enhancement
- 3-fold
- Long-R3 IGF-I
Source sentences
A similar 3-fold enhancement (P < 0.01) was noted in response to Long-R3 IGF-I, but not in response to [Ala(31),Leu(60)]IGF-I.
1 context sentence(design, population, supporting numbers)
Telomerase activity was assayed in LAPC-4, PC-3, and DU-145 prostate cancer cell lines treated with and without IGF-I/IGF-I analogs.